Prospective Study on Ennovate® Pedicle Screw Fixation in Isthmic Spondylolisthesis Patients (ENNOVIST)

September 17, 2019 updated by: Aesculap AG

Prospective Study on Clinical and Radiological Results With Ennovate® Pedicle Screw Fixation in Isthmic Spondylolisthesis Patients

The present study is planned to demonstrate the efficacy and safety of a new pedicle screw system for the specific indication of isthmic spondylolisthesis, as this condition concerns relatively young patients requiring good fixation of the performed reposition to come to satisfactory clinical results.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

Adult Isthmic spondylolisthesis, which is associated with "spondylolysis," is defined as an osseous discontinuity of the vertebral arch at the isthmus (the pars interarticularis), which usually occurs in the fifth lumbar vertebra. The prevalence of isthmic spondylosis is proposed to be about 6% to 26% in different studies. The European Spine Tango registry found 15%. It is proposed to affect more men than women. Conservative treatments including braces, physical therapy, and medication are shown to be effective for some patients; however, surgical treatments are mainly the final effective treatment. There are several different options for surgery among which posterolateral fusion (PLF) is considered as the method of choice. It is shown that PLF is more effective than conservative treatments such as exercise. The fusion helps to fix the motion of the affected segment and therefore, might lead to pain reduction. Decompression, supplemental instrumentation, and supplemental anterior column support are also considered for treatment. These treatment strategies can be used separately or in any combination; however, studies trying to compare separate treatments with a combination of them have led to inconsistent results.

Supplementary pedicle screws might be added to fusion methods for fixation and it is proposed that they have the ability to correct the deformity, reduce the listhesis, and increase the fusion rates, although a majority of the studies comparing instrumented PLF and noninstrumented PLF could not show the superiority of instrumented approaches. The literature has been reviewed in 2000 already, and the method has already been proved to be "practical, safe, and effective" for various spinal indications. Other authors found a better result for isthmic spondylolisthesis patients with posterior lumbar interbody Fusion (PLIF), vs. PLF, especially for high grade isthmic spondylolisthesis.

The present study is planned to demonstrate the efficacy and safety of a new pedicle screw system for the specific indication of isthmic spondylolisthesis, as this condition concerns relatively young patients requiring good fixation also in the long-term.

Study Type

Observational

Enrollment (Actual)

2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frankfurt am Main, Germany, 60590
        • Klinikum der J. W. Goethe-Universität, Klinik für Allgemein- und Visceralchirurgie
      • Koblenz, Germany, 56073
        • Katholisches Klinikum Koblenz
      • Offenbach, Germany, 63069
        • Sana Klinikum Offenbach GmbH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

adult patients

Description

Inclusion Criteria:

  • Symptomatic single-level IS (L4-S1), (VAS > 30mm, treated conservatively for a minimum of 6 months)
  • Isthmic Spondylolisthesis Meyerding grade I and II
  • Signed Informed Consent of the patient regarding the participation in this study

Exclusion Criteria:

  • Multilevel IS
  • Severe degenerative changes of cranial adjacent level (disc height of <50% of the next healthy segment,
  • Previous lumbar spine surgery except microdiscectomy or micro- decompression of the index level
  • Patients psychically or mentally not able to give or refuse consent
  • Patients psychically or mentally not able to answer the questions regarding their health status and quality of life
  • Pregnancy (current or planned)
  • BMI >35
  • Systemic or local infection
  • Chemotherapy or radiation ongoing
  • Desire of early retirement (running pension request)
  • All contraindications as listed in the instructions for use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Ennovate
Implantation of an Ennovate® internal fixation
Internal fixation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leg pain
Time Frame: 1 year
Leg Pain measured by Visual analogue scale (VAS) after 1 year follow-up: measured by Visual Analogue Scale: The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leg Pain
Time Frame: Preoperative, 3 months, 6 months
Leg Pain measured by Visual analogue scale (VAS) at all timepoints except 1 year; measured by Visual Analogue Scale: The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.
Preoperative, 3 months, 6 months
Back Pain
Time Frame: Preoperative, 3 months, 6 months, 1 year
Back Pain measured by Visual analogue scale (VAS) at all timepoints; measured by Visual Analogue Scale: The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.
Preoperative, 3 months, 6 months, 1 year
Functional Disability
Time Frame: Preoperative, 3 months, 6 months, 1 year
Measured by Oswestry Disability Index (ODI) at all timepoints; The ODI is an index derived from the Oswestry Low Back Pain Questionnaire to quantify disability for low back pain. The self-completed questionnaire contains ten Topics: intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Preoperative, 3 months, 6 months, 1 year
Patient satisfaction
Time Frame: 3 months, 6 months, 1 year
Patient Satisfaction with Operation Result (very high / high / medium / low / very low)
3 months, 6 months, 1 year
Quality of Life
Time Frame: preoperative, 3 months, 6 months, 1 year
Quality of Life measured by EQ-5D-5L Questionnaire: The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group in 2009 to improve the instrument's sensitivity and to reduce ceiling effects, as compared to the EQ-5D-3L. The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety / depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
preoperative, 3 months, 6 months, 1 year
Clinical Complications
Time Frame: intraoperative, 3 months, 6 months, 1 year
Adverse Events (AE) and Serious Adverse Events (SAE) forms filled at all timepoints intraop and postop
intraoperative, 3 months, 6 months, 1 year
Fusion status
Time Frame: 3 months, 6 months, 1 year
Fusion assessment (acc. to Bridwell)
3 months, 6 months, 1 year
Radiographically assessed complications
Time Frame: 3 months, 6 months, 1 year
Construct stability, loosening, implant breakage, other adverse events (Osteolysis, screw misplacement, device migration)
3 months, 6 months, 1 year
Loss of Reduction of the Reposition [degree]
Time Frame: 3 months, 6 months, 1 year
Results regarding the maintenance of the reposition of the isthmic spondylolisthesis throughout the follow-up; loss of reduction during follow-up measured in [degree]
3 months, 6 months, 1 year
Range of Motion
Time Frame: 3 months, 6 months, 1 year
Range of motion (angular and translational; degrees/mm)
3 months, 6 months, 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 31, 2018

Primary Completion (ACTUAL)

January 18, 2019

Study Completion (ACTUAL)

January 18, 2019

Study Registration Dates

First Submitted

April 16, 2018

First Submitted That Met QC Criteria

April 16, 2018

First Posted (ACTUAL)

April 25, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 18, 2019

Last Update Submitted That Met QC Criteria

September 17, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • AAG-O-H-1619

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Isthmic Spondylolisthesis

Clinical Trials on fusion

3
Subscribe